Remdesivir Races Through EU Review

Gilead Sciences’ remdesivir could get the nod from the European Medicines Agency this week as a treatment for COVID-19, paving the way for swift EU approval.

Drug remdesivir for covid 19 coronavirus treatment
The EMA is assessing Gilead's marketing application for remdesivir • Source: Shutterstock

The European Medicines Agency could this week recommend that Gilead Sciences’ antiviral drug remdesivir be approved for treating COVID-19 across the EU.

Gilead is seeking conditional approval for remdesivir in the EU and the marketing authorization application (MAA) for the investigational drug...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Product Reviews

More from Pink Sheet